Catecholamine secretion in obstructive sleep apnoea (OSA)

A. S. Haque, A. G. Davison, T. Tan, K. Metcalfe (Westcliff on Sea, United Kingdom)

Source: Annual Congress 2005 - Cardiovascular consequences of OSA
Session: Cardiovascular consequences of OSA
Session type: Poster Discussion
Number: 362
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. S. Haque, A. G. Davison, T. Tan, K. Metcalfe (Westcliff on Sea, United Kingdom). Catecholamine secretion in obstructive sleep apnoea (OSA). Eur Respir J 2005; 26: Suppl. 49, 362

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cortisol metabolism in obstructive sleep apnea (OSA)
Source: Eur Respir J 2002; 20: Suppl. 38, 215s
Year: 2002

Leptin in obstructive sleep apnea
Source: Eur Respir J 2001; 18: Suppl. 33, 333s
Year: 2001

NT-proBNP in obstructive sleep apnoea (OSA)
Source: Eur Respir J 2006; 28: Suppl. 50, 415s
Year: 2006

Increased rates of obstructive sleep apnea (OSA) in COVID-19-patients
Source: Virtual Congress 2021 – Sleep across the lifespan in the new era of COVID - 19
Year: 2021


Screening for obstructive sleep apnea (OSA) in acromegaly
Source: Virtual Congress 2020 – Screening methods and diagnostic tools for obstructive sleep apnoea
Year: 2020


Predictors of hypercapnia in obstructive sleep apnoea (OSA)
Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control
Year: 2010

Hyperuricaemia in females with obstructive sleep apnoea (OSA)
Source: Eur Respir J 2003; 22: Suppl. 45, 91s
Year: 2003

Daytime hypercapnia in patients with obstructive sleep apnoea syndrome (OSAS)
Source: Eur Respir J 2002; 20: Suppl. 38, 493s
Year: 2002

Hyperuricaemia in males with obstructive sleep apnoea (OSA)
Source: Eur Respir J 2001; 18: Suppl. 33, 334s
Year: 2001

Glucose metabolism abnormalities in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012

Bronchial inflammation in obstructive sleep apnea (OSA) patients
Source: Eur Respir J 2003; 22: Suppl. 45, 466s
Year: 2003

Daytime ventilatory instability in obese patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2001; 18: Suppl. 33, 334s
Year: 2001

Prevalence of nocturia in obstructive sleep apnoea (OSA)
Source: Eur Respir J 2006; 28: Suppl. 50, 646s
Year: 2006

Determinants of hypercapnia in obese obstructive sleep apnea (OSA) patients
Source: Eur Respir J 2004; 24: Suppl. 48, 447s
Year: 2004

Metabolic syndrome in obstructive sleep apnoea patients
Source: Annual Congress 2007 - Sleep apnoea
Year: 2007


Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010

Disturbances of respiratory muscles in patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2006; 28: Suppl. 50, 418s
Year: 2006

Comparison of plasma NT-proBNP level in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA)
Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep
Year: 2008


Effect of smoking on obstructive sleep apnoea (OSA)
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007


Hypertension and obstructive sleep apnoea
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006